Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1755 | Hospital anxiety and depression scale Wiki | 1.00 |
| drug3178 | Quality of Life Wiki | 1.00 |
| drug1908 | Impact Event Score Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D016638 | Critical Illness NIH | 0.12 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
A multicenter prospective cohort study performed at 6 major teaching hospitals in Southern Norway to study patient reported outcomes, lung function and pulmonary CT in patients at 3 and 12 months after hospitalization for coronavirus disease 2019 (COVID-19).
Description: L
Measure: Forced vital capacity Time: 3 monthsDescription: L
Measure: Forced vital capacity Time: 12 monthsDescription: mmol/kPa*min
Measure: Gas diffusion capacity of carbon monoxide Time: 3 monthsDescription: mmol/kPa*min
Measure: Gas diffusion capacity of carbon monoxide Time: 12 monthsDescription: Unit
Measure: modified Medical Respiratory Council Dyspnea Scale Time: 6 weeksDescription: Unit
Measure: modified Medical Respiratory Council Dyspnea Scale Time: 3 monthsDescription: Unit
Measure: modified Medical Respiratory Council Dyspnea Scale Time: 12 monthsDescription: Number of opacities in one lung zone
Measure: Parenchymal opacities of the lungs Time: 3 monthsDescription: Number of opacities in one lung zone
Measure: Parenchymal opacities of the lungs Time: 12 monthsDescription: L
Measure: Forced expiratory capacity during 1st second of expiration Time: 3 monthsDescription: L
Measure: Forced expiratory capacity during 1st second of expiration Time: 12 monthsDescription: Percentage
Measure: FEV1/FVC Time: 3 monthsDescription: Percentage
Measure: FEV1/FVC Time: 12 monthsDescription: mmol/kPa*min*L
Measure: Gas diffusion capacity adjusted for alveolar ventilation (KCO) Time: 3 monthsDescription: mmol/kPa*min*L
Measure: Gas diffusion capacity adjusted for alveolar ventilation (KCO) Time: 12 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports